A study of how Russians from age 4 to 65+ years
respond to a 3-in-1 combined vaccine against
diphtheria, tetanus, and whooping cough
GSK would like to thank all the adults, adolescents and children, and
their parents, who took part in this clinical study. We think it is
important that you know the study results. We hope it helps you
understand and feel proud about your important role in medical
research.